Use of pancreatic duct stents after pancreaticoduodenectomy

Richard D. Schulick

Research output: Contribution to journalArticle

Abstract

After pancreaticoduodenectomy, the pancreatic anastomosis carries the highest risk of leak and cause of morbidity and mortality. In this review article, three randomized controlled clinical trials and a fourth prospective trial focused on pancreaticoduodenectomy that contribute to level-one evidence are examined. The Johns Hopkins group demonstrated that internal pancreatic duct stenting did not decrease the frequency or severity of postoperative pancreatic fistulas. The Queen Mary Hospital group demonstrated that external drainage of the pancreatic duct with a stent reduced the leakage rate of pancreaticojejunostomy after pancreaticoduodenectomy. The University of Athens group demonstrated that internal stenting of the pancreaticojejunostomy anastomosis did not reduce the incidence of pancreatic fistula and related complications. Finally, the French Surgery Research Group demonstrated that the use of an external stent through the pancreatic anastomosis reduced the pancreatic fistula rate. In summary, two studies do not demonstrate an advantage to the use of internal pancreatic duct stents and two studies demonstrate a possible advantage to the use of external pancreatic duct stents, especially in highest risk patients with soft glands and small pancreatic ducts.

Original languageEnglish (US)
Pages (from-to)775-778
Number of pages4
JournalJournal of Hepato-Biliary-Pancreatic Sciences
Volume18
Issue number6
DOIs
StatePublished - Nov 2011

Fingerprint

Pancreaticoduodenectomy
Pancreatic Ducts
Stents
Pancreatic Fistula
Pancreaticojejunostomy
Drainage
Randomized Controlled Trials
Morbidity
Mortality
Incidence
Research

Keywords

  • Fistula
  • Pancreatic duct stent
  • Pancreaticoduodenectomy

ASJC Scopus subject areas

  • Hepatology
  • Surgery

Cite this

Use of pancreatic duct stents after pancreaticoduodenectomy. / Schulick, Richard D.

In: Journal of Hepato-Biliary-Pancreatic Sciences, Vol. 18, No. 6, 11.2011, p. 775-778.

Research output: Contribution to journalArticle

@article{32845273fb8842f68cabf0bcee7b55a2,
title = "Use of pancreatic duct stents after pancreaticoduodenectomy",
abstract = "After pancreaticoduodenectomy, the pancreatic anastomosis carries the highest risk of leak and cause of morbidity and mortality. In this review article, three randomized controlled clinical trials and a fourth prospective trial focused on pancreaticoduodenectomy that contribute to level-one evidence are examined. The Johns Hopkins group demonstrated that internal pancreatic duct stenting did not decrease the frequency or severity of postoperative pancreatic fistulas. The Queen Mary Hospital group demonstrated that external drainage of the pancreatic duct with a stent reduced the leakage rate of pancreaticojejunostomy after pancreaticoduodenectomy. The University of Athens group demonstrated that internal stenting of the pancreaticojejunostomy anastomosis did not reduce the incidence of pancreatic fistula and related complications. Finally, the French Surgery Research Group demonstrated that the use of an external stent through the pancreatic anastomosis reduced the pancreatic fistula rate. In summary, two studies do not demonstrate an advantage to the use of internal pancreatic duct stents and two studies demonstrate a possible advantage to the use of external pancreatic duct stents, especially in highest risk patients with soft glands and small pancreatic ducts.",
keywords = "Fistula, Pancreatic duct stent, Pancreaticoduodenectomy",
author = "Schulick, {Richard D.}",
year = "2011",
month = "11",
doi = "10.1007/s00534-011-0430-5",
language = "English (US)",
volume = "18",
pages = "775--778",
journal = "Journal of Hepato-Biliary-Pancreatic Sciences",
issn = "1868-6974",
publisher = "Springer Verlag",
number = "6",

}

TY - JOUR

T1 - Use of pancreatic duct stents after pancreaticoduodenectomy

AU - Schulick, Richard D.

PY - 2011/11

Y1 - 2011/11

N2 - After pancreaticoduodenectomy, the pancreatic anastomosis carries the highest risk of leak and cause of morbidity and mortality. In this review article, three randomized controlled clinical trials and a fourth prospective trial focused on pancreaticoduodenectomy that contribute to level-one evidence are examined. The Johns Hopkins group demonstrated that internal pancreatic duct stenting did not decrease the frequency or severity of postoperative pancreatic fistulas. The Queen Mary Hospital group demonstrated that external drainage of the pancreatic duct with a stent reduced the leakage rate of pancreaticojejunostomy after pancreaticoduodenectomy. The University of Athens group demonstrated that internal stenting of the pancreaticojejunostomy anastomosis did not reduce the incidence of pancreatic fistula and related complications. Finally, the French Surgery Research Group demonstrated that the use of an external stent through the pancreatic anastomosis reduced the pancreatic fistula rate. In summary, two studies do not demonstrate an advantage to the use of internal pancreatic duct stents and two studies demonstrate a possible advantage to the use of external pancreatic duct stents, especially in highest risk patients with soft glands and small pancreatic ducts.

AB - After pancreaticoduodenectomy, the pancreatic anastomosis carries the highest risk of leak and cause of morbidity and mortality. In this review article, three randomized controlled clinical trials and a fourth prospective trial focused on pancreaticoduodenectomy that contribute to level-one evidence are examined. The Johns Hopkins group demonstrated that internal pancreatic duct stenting did not decrease the frequency or severity of postoperative pancreatic fistulas. The Queen Mary Hospital group demonstrated that external drainage of the pancreatic duct with a stent reduced the leakage rate of pancreaticojejunostomy after pancreaticoduodenectomy. The University of Athens group demonstrated that internal stenting of the pancreaticojejunostomy anastomosis did not reduce the incidence of pancreatic fistula and related complications. Finally, the French Surgery Research Group demonstrated that the use of an external stent through the pancreatic anastomosis reduced the pancreatic fistula rate. In summary, two studies do not demonstrate an advantage to the use of internal pancreatic duct stents and two studies demonstrate a possible advantage to the use of external pancreatic duct stents, especially in highest risk patients with soft glands and small pancreatic ducts.

KW - Fistula

KW - Pancreatic duct stent

KW - Pancreaticoduodenectomy

UR - http://www.scopus.com/inward/record.url?scp=80255137019&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80255137019&partnerID=8YFLogxK

U2 - 10.1007/s00534-011-0430-5

DO - 10.1007/s00534-011-0430-5

M3 - Article

C2 - 21915642

AN - SCOPUS:80255137019

VL - 18

SP - 775

EP - 778

JO - Journal of Hepato-Biliary-Pancreatic Sciences

JF - Journal of Hepato-Biliary-Pancreatic Sciences

SN - 1868-6974

IS - 6

ER -